Akron can compete with US's largest tech hubs — if it has the right policies | Opinion
Akron should build on its recent successes and make our regional economy a force to be reckoned with, writes former Fairlawn ...
MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism
AvailTM trial exceeded enrollment target; topline results expected in Q3 2025CARMEL, Ind., March 03, 2025 (GLOBE NEWSWIRE) -- ...